HispanicBusiness.com

Biotechnology Competition: Winners HispanicBusiness.com Business, law, science and medical students from top universities around the nation converged at the Wake Forest University Schools of Business on February 8-9 for the 4th Annual Biotechnology Conference and Case Competition. The eight student teams ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEGGYZHrXDIpqD7AK1HCgMkw_Ikng&url=http://www.hispanicbusiness.com/2013/2/21/biotechnology_competition_winners.htm

Irish Times

Never a better time to eat a burger Irish Times There has never been a better time to dust down your CV if you have experience in animal or molecular genetics. DNA testing laboratories, such as Identigen in Dublin, cannot keep up with the demand for testing from the industry and regulators. DNA ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHSHrKdwI1V_nmTokhXM-KRQ6pIZw&url=http://www.irishtimes.com/newspaper/weekend/2013/0223/1224330397694.html

W.Va. fisheries biologists using new methods San Francisco Chronicle "With the techniques developed in the field of molecular genetics, we are able to tell why some strains of fish do better than others. It started in the early 1980s when people started studying Florida-strain largemouth bass, and it just exploded from ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG3qhVsBhJ19qrl1mFUvzL_YQlUiA&url=http://www.sfgate.com/news/article/W-Va-fisheries-biologists-using-new-methods-4300492.php

Horsetalk

Concerns over spread of antibiotic resistant genes Horsetalk ... known as ARGs, some at levels 192 to 28,000 times higher than the control samples, said study co-author James Tiedje, Michigan State University Distinguished Professor of microbiology and molecular genetics and of plant, soil and microbial sciences.

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGNDK3Tfd1-6kcMbxngayIUibNTFQ&url=http://horsetalk.co.nz/2013/02/23/concerns-spread-antibiotic-resistant-genes/

Know Your Neighors: Understanding the Muslim Community in Twin Falls Twin Falls Times-News He holds a doctorate degree in plant molecular genetics from University of Helsinki in Finland and the Scottish Crop Research Institute. Eujayl immigrated to the United States when his name was drawn in the U.S. Diversity Immigrant Visa program (Visa ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGZuelsCZWQafRsWpMrI8mxZkBoBA&url=http://magicvalley.com/entertainment/events/know-your-neighors-understanding-the-muslim-community-in-twin-falls/article_faae769c-d17d-5d9d-9d2e-110e5a977ded.html

Popular Science

Silicon Valley Tycoons Bestow Surprise $33 Million Prize On 11 Unsuspecting ... Popular Science Hans Clevers, Professor of Molecular Genetics at Hubrecht Institute; For describing the role of Wnt signaling in tissue stem cells and cancer. Titia de Lange, Leon Hess Professor, Head of the Laboratory of Cell Biology and Genetics, and Director of the ... Mark Zuckerberg, Sergey Brin, Other Tech Moguls Launch 'Breakthrough Prize ...Huffington Post Breakthrough Prize: Mark Zuckerberg, Sergey Brin And Others Launch Huge ...Huffington Post UK all 118 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEvm08fNGRujVlXpNqzeNm4HgLZ4A&url=http://www.popsci.com/science/article/2013-02/silicon-valley-tycoons-bestow-new-33-million-prize-11-unsuspecting-cancer-researchers

Discovery Institute

Speaking for "Answers in Genesis," Creationist Georgia Purdom Hits a Nail on ... Discovery Institute That's a distinction that many Darwinists egregiously and intentionally muddle, leaving the media and much of the public confused. Dr. Purdom, who has her degree in molecular genetics, works with the organization Answers in Genesis. In a brief video ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF-hNVs4NoQccLGRQIVzNOzyCZuZQ&url=http://www.evolutionnews.org/2013/02/for_answers_in_069431.html

Cure for Common Hangover? 'Pill' Mimics Action of Human Liver in Fighting ... Science Daily (press release) Additional authors of the research include Wei Wei of UCLA Engineering; Ming Yan of UCLA Engineering and the UCLA Department of Microbiology, Immunology and Molecular Genetics; Mo Yin Lau, Jay Hu, Hui Han and Cheng Ji of the Keck School of ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFXlgKHS6ZEVsiEOZF6IuiM_tulpg&url=http://www.sciencedaily.com/releases/2013/02/130220114337.htm

Michael Friedman City of Hope photo

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/DWx8xx07ZOY/city-of-hope-exec-will-leave-california.html

The $3 billion California stem cell
agency appears unlikely to make any changes in who gets the cash from
any commercial products that its research grants help finance despite
recommendations from the Institute of Medicine(IOM).

“Because CIRM is a new institution
without a track record to reassure stakeholders, and because its
finite funding timeline means as yet unknown agencies will be
enforcing these policies years down the road, CIRM should “propose
regulations that specify who will have the power and authority to
assert and enforce in the future rights retained by the state” in
CIRM IP, specifically referring to march-in rights, access plans and
revenue sharing....

“Second, as other sources of funding
become more prevalent, the agency should “reconsider whether its
goal of developing cures would be better served by harmonizing CIRM’s
IP policies wherever possible with the more familiar policies of the
BayhDole Act.”

“CIRM staff has engaged in
preliminary discussions several years ago with other agencies
regarding future enforcement of CIRM’s regulations and agreements.
Staff proposes to restart those discussions and return to the
Subcommittee (or the Board) with a formal proposal to address future
enforcement of CIRM’s IP regulations.”

“In light of the IOM’s own
recognition that it may be premature to assess whether CIRM’s
regulations will act as a deterrence to future investment, the fact
that a number of CIRM’s regulations have been codified in statutes
and CIRM’s positive progress in its industry engagement efforts to
date, although quite early, CIRM staff proposes to continue to
monitor this area and not to pursue any changes at this time.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/xvosTob7Zo0/monitoring-cash-and-ip-at-california.html

The California stem cell agency's
editorial road show paid off a bit again this week with a mildly
approving editorial in the Oakland Tribune.

“California
must get its stem cell house in order”

“...{T)he agency must prove that it
understands how to properly handle the public's money. …. If
the stem cell agency can establish a record as a good steward of
public dollars to finance brilliant science, it can continue to play
a useful role in stimulating and guiding research to bring the
potential cures from stem cell research to fruition.

“If it cannot do that, it will be
just another expensive Tyrannosaurus rex.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/tMt6gs55Yvs/half-full-half-empty-editorial-on.html

Should the scientists who evaluate
and score the applications for $3 billion in taxpayer funds be
required to publicly disclose their financial interests?

“(T)he FPPC believes that, under
state regulations, working group members (including grant reviewers)
may act as decision makers if they make substantive recommendations
that are, over an extended period, regularly approved without
significant amendment or modification by the committee. Thus, as
decision makers, working group members would need to be subject to
the conflict-of-interest code. This would mean that working groups
would be subject not only to the (public) financial disclosure requirements of
the Political Reform Act but also to the prohibition against a member
participating in a government decision in which that member has a
disqualifying financial interest and may be subject to the penalties
that may be imposed on individuals who violate that act.”

"We have given careful
consideration to your recommendation and have decided it is not
appropriate to implement at this time. In almost three years of
operation and approval of four rounds of grants, the recommendations
of the CIRM working groups have never been routinely and/or regularly
adopted by the ICOC. Until the time that such a pattern is detected,
the question you suggest we raise with the attorney general is
entirely hypothetical, and is therefore not appropriate for
submission. We will, however, continue to monitor approvals for such
a pattern and will reconsider our decision if one emerges."

“No matter what the circumstances --
if an independent observer might reasonably question whether the
individual's professional actions or decisions are determined by
considerations of personal financial gain, the relationship should be
disclosed to the public during presentations, in publications,
teaching or other public venues.”

"The public trust in what we do is
just essential, and we cannot afford to take any chances with the
integrity of the research process."

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/oma-MLcANoY/time-for-public-disclosure-of-financial.html

By Cheche V. Moral

I DID it because it worked on my wifes cousin, and because of what I read about it, says Joe Concepcion of his stem-cell therapy. ALANAH TORRALBA

Last of two parts

Jose S. Concepcion Jr., at 81, still goes to the office daily, and, to his wifes chagrin, is quite restless and bullheaded, sour if he has nothing to keep himself busy.

He does crazy things! Like, if he gets hold of a book, hell bring it and photocopy everything, says Marivic Concepcion, who has been married for 56 years to the RFM Corp. chair, Namfrel (National Citizens Movement for Free Election) founder and former trade secretary. He needs a caregiver but he wont allow it. He could fall!

Her husband, however, insists he feels excellent. I feel so good when I wake up. I dont feel tired, says the activist known to many as Joecon.

Concepcion attributes this renewed strength and vigor to a procedure he had undergone not long ago, and of which he has been a vocal and unpaid advocate: stem-cell therapy.

Astonishing effects

The tycoon received his treatment from a German doctor named Christoph Ganss, who comes to the Philippines every three or four months to speak about his company and the benefits of stem-cell banking, according to the Concepcions. Ganss is the founder of Ticeba (Tissue & Cell Banking), a tissue bank for stem cells and laboratory in Heidelberg.

The couple heard of Dr. Ganss from Ms Concepcions cousin who underwent the treatment in Germany.

Follow this link:
Jose “Joecon” Concepcion Jr: ‘I’m now a believer in stem-cell therapy. The proof is me!’

Baylie Faella Pre-Stem Cell Therapy at Abbott Animal Hospital in Rehoboth, MA
Baylie Faella, a 7 year old Lab pre-stem cell therapy who underwent a torn ACL repair. She also suffered from atopy (allergies) and had lesions on her body.

By: Ashraf Gomaa

See the rest here:
Baylie Faella Pre-Stem Cell Therapy at Abbott Animal Hospital in Rehoboth, MA - Video

Parkinson #39;s Stem Cell Therapy - Group 28 pm
BIOL 1103 Group 28 pm Stem Cell Application Assignment Sources: Euro Stem Cell research: http://www.eurostemcell.org Michael J. Fox Foundation: http://www.michaeljfox.org

By: thehaysdays

See the original post here:
Parkinson's Stem Cell Therapy - Group 28 pm - Video

Now, thanks to participating veterinarians like Dr. Karen Derfuss, DVM, from Branchburg Animal Hospital, who will be conducting a new double stem cell therapy procedure on Tuesday, Feb. 26, and the procedure itself, developed by MediVet America, a new kind of treatment is available for dogs, Auggie and Chloe, and other beloved pets in the Branchburg area.

This new procedure marks a major milestone in regenerative veterinary medicine, said MediVet-America spokesman, Dr. Mike Hutchinson, D.V.M., a leading practitioner in stem cell therapy who has performed more than 400 adipose-derived stem cell treatments on dogs and cats. MediVets superior results made me a believer, and Im excited to share this news with my colleagues.

The procedure uses adult animal stem cell technology and the bodys own regenerative healing power. No embryonic stem cells are used. MediVets kit and equipment enable veterinarians to remove a sample of fat from the pet, separate stem cells from the fat, then activate and inject the cells into the affected area. The entire procedure is all done in-clinic and on the same day.

Within about one month, most animals can be removed from pain and anti-inflammatory drugs. Results show animals that had been unable to climb stairs or jump, now are walking, running and playing.

MediVet is a global leader in veterinary science, with over 1,000 clinics practicing this incredible technology in the US, Mexico, Canada and 28 other countries

About the two dogs:

Auggie is a nine year old loving beagle and a Fathers Day Gift for dad. He is suffering from hip dysplasia, which is an abnormal formation of the hip socket that, in its more severe form, can eventually cause crippling lameness and painful arthritis of the joints. Derfuss is the only doctor in the area who has been certified by MediVet America to perform this double procedure. The stem cell procedure is an affordable and non-invasive alternative to FHO (femoral head osteopathy) surgery, which was originally planned for Auggie.

Chloe is a beautiful 11 year old golden retriever who suffers from bilateral arthritic hips and long term inflammation issues. It was decided to use this new technology to treat Chloes ailments as an alternative to expensive and invasive hip replacement surgery.

Go here to read the rest:
First ever double stem cell therapy procedure to be performed by Branchburg veterinarian

Public release date: 21-Feb-2013 [ | E-mail | Share ]

Contact: Sooike Stoops sooike.stoops@vib.be 32-924-46611 VIB (the Flanders Institute for Biotechnology)

Cell therapy is a promising alternative to tissue and organ transplantation for diseases that are caused by death or poor functioning of cells. Considering the ethical discussions surrounding human embryonic stem cells, a lot is expected of the so-called 'induced pluripotent stem cells' (iPS cells). However, before this technique can be applied effectively, a lot of research is required into the safety and efficacy of such iPS cells. VIB scientists associated to the UGent have developed a mouse model that can advance this research to the next step.

Lieven Haenebalcke (VIB/UGent): "iPS cells have enormous therapeutic potential, but require more thorough testing before they can be used for such purposes. Using our new mouse model, we can study which mechanisms determine the identity of a cell. This knowledge is essential before we can use cell therapy for regenerative medicine."

Jody Haigh (VIB/UGent): "If we want to give cell therapy a future, then we must continue this type of research and invest in the further development of such technologies. This will result in an improved insight into cellular identity and in the long term safer options of applying iPS cells or cells derived from iPS cells in clinical studies."

Cell therapy replacing cells to provide a cure

Cell therapy is the replacement of lost or poorly functioning cells in patients. For example, such cell therapies could be used to repair the heart muscle after a heart attack, joints affected by arthritis, the pancreas in diabetes or the spine in certain forms of paralysis. This requires cells that are able to multiply in the laboratory and that can be converted to healthy cells of the desired cell type. Human embryonic stem cells meet these criteria, but they are ethically controversial.

iPS cells a promising alternative to embryonic stem cells

Shinya Yamanaka recently developed a fairly simple method to reprogram differentiated cells such as skin cells back to stem cells, so-called "induced pluripotent stem cells" (iPS cells). This earned him the Nobel Prize for Medicine in 2012 (shared with John Gurdon). These iPS cells can be generated using only 4 "reprogramming factors".

As is the case with embryonic stem cells, these iPS cells can be used to produce other cell types, such as heart muscle cells or nerve cells. They can also be cultured indefinitely and there are no ethical objections as they are not obtained from human embryos left over after IVF, but from adult individuals. Furthermore, iPS cells are obtained from the patient and this reduces the risk of rejection during therapeutic applications.

Read the rest here:
Cell therapy a little more concrete thanks to VIB research

Feb. 21, 2013 Cell therapy is a promising alternative to tissue and organ transplantation for diseases that are caused by death or poor functioning of cells. Considering the ethical discussions surrounding human embryonic stem cells, a lot is expected of the so-called 'induced pluripotent stem cells' (iPS cells). However, before this technique can be applied effectively, a lot of research is required into the safety and efficacy of such iPS cells. VIB scientists associated to the UGent have developed a mouse model that can advance this research to the next step.

Lieven Haenebalcke (VIB/UGent): "iPS cells have enormous therapeutic potential, but require more thorough testing before they can be used for such purposes. Using our new mouse model, we can study which mechanisms determine the identity of a cell. This knowledge is essential before we can use cell therapy for regenerative medicine."

Jody Haigh (VIB/UGent): "If we want to give cell therapy a future, then we must continue this type of research and invest in the further development of such technologies. This will result in an improved insight into cellular identity and -- in the long term -- safer options of applying iPS cells or cells derived from iPS cells in clinical studies."

Cell therapy -- replacing cells to provide a cure

Cell therapy is the replacement of lost or poorly functioning cells in patients. For example, such cell therapies could be used to repair the heart muscle after a heart attack, joints affected by arthritis, the pancreas in diabetes or the spine in certain forms of paralysis. This requires cells that are able to multiply in the laboratory and that can be converted to healthy cells of the desired cell type. Human embryonic stem cells meet these criteria, but they are ethically controversial.

iPS cells -- a promising alternative to embryonic stem cells

Shinya Yamanaka recently developed a fairly simple method to reprogram differentiated cells -- such as skin cells -- back to stem cells, so-called "induced pluripotent stem cells" (iPS cells). This earned him the Nobel Prize for Medicine in 2012 (shared with John Gurdon). These iPS cells can be generated using only 4 "reprogramming factors."

As is the case with embryonic stem cells, these iPS cells can be used to produce other cell types, such as heart muscle cells or nerve cells. They can also be cultured indefinitely and there are no ethical objections as they are not obtained from human embryos left over after IVF, but from adult individuals. Furthermore, iPS cells are obtained from the patient and this reduces the risk of rejection during therapeutic applications.

Essential research possible

Before iPS cells can be used effectively and safely as a therapy, it is essential that we gain clear insight into which molecular mechanisms determine the identity of a cell; why and how a cell develops into -- for example -- a heart muscle cell, a nerve cell or a blood cell. In order to do so, Lieven Haenebalcke and Jody Haigh have developed a mouse model that will enable them to conduct this research. They succeeded in creating iPS cells from a variety of mouse cells. Furthermore, the new model allows the investigators to replace the 4 reprogramming factors in these iPS cells efficiently with specific genes in order to create targeted different cell types, such as functional heart muscle cells.

The rest is here:
Cell therapy: New mouse model promises to advance research on induced pluripotent stem cells

Stem Cell Therapy - Arthritis Therapy
Stem cell therapy for dogs, cats, and horses has been around for a few years. But as companies compete, the technology keeps improving. And today, a Hillsborough County vet clinic became only the second in the Bay Area to offer same-day procedures.

By: EhrlichAnimalHospita

Continued here:
Stem Cell Therapy - Arthritis Therapy - Video

Stem Cell Therapy - Ehrlich Animal Hospital #39;s Arthritis Therapy Center
Ehrlich Animal Hospital offers several degrees of specialty arthritis therapies and treatments that may not be currently available at other local animal hospitals. Our hospital is unique in that we offer cutting edge arthritis therapy technologies: therapeutic laser treatments, injectable medications and oral medications to reduce inflammation and discomfort.

By: EhrlichAnimalHospita

Read more:
Stem Cell Therapy - Ehrlich Animal Hospital's Arthritis Therapy Center - Video